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1. Introduction 
Nuclear deposits of glycogen, are usually related 
to pathological conditions. These include human 
hepatocytes following prednisolone treatment [ 11, in 
liver biopsies obtained in cases of hepatitis [2,3], in 
Novikoff hepatoma cells [4] and in Erlich ascites 
[5-81 where glycogen synthase was reported in puri- 
fied nuclei [9] and the accumulation of nuclear gly- 
cogen demonstrated by electron microscopy and 
autoradiography [lo]. In a limited number of reports 
an abnormal deposition of glycogen in the nucleus 
was linked with diabetes [ 111. We have examined the 
activity of glycogen synthase in liver nuclei of normal 
and diabetic rats. Here we demonstrate low levels of 
nuclei-associated activity of glycogen synthase. The 
electron-microscopic data indicate that glycogen syn- 
thase activity associated with liver nuclei is most 
probably an artifact of preparation. 
2. Materials and methods 
Male Wistar rats (250-350 g) fed ad libitum, were 
used throughout. Livers perfused free of blood were 
rapidly homogenized and nuclei isolated as in [ 121. 
Briefly, nuclei were sedimented by ultracentrifuga-. 
tion from 10% homogenates prepared in 2.2 M 
sucrose, 3 mM CaClz and 0.5 mM Tris-HCl (pH 7.4). 
The nuclear pellet was resuspended in 1 M sucrose, 
1 mM CaC&, 0.5 mM Tris-HCl (pH 7.4) sedimented 
by centrifugation (3000 X g for 5 mm) and resus- 
pended in the same medium. Whole homogenates 
were assayed after dilution (with 0.5 mM Tris-HCl 
(pH 7.4) 2.2-fold. Glycogen synthase was assayed as 
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in [ 131 at higher specific radioactivity of UDP-[‘4C] 
glucose. Assays were incubated at 30°C in triplicate. 
Mild diabetes was induced by treating rats with strep- 
tozotocin (50 mg/kg body wt) and monitored by 
urine volumes. The treated animals were able to main- 
tain themselves howing little, or no weight gain when 
compared to control animals. Nuclear pellets were 
fixed and processed for electron microscopy as in 
[ 141. The sources of chemicals and radiochemicals 
were as in [ 14,151. All other chemicals were of ana- 
lytical grade. 
3. Results 
The specific activity of glycogen synthase (I t D 
form, assayed in the presence of 6.6 mM glucose 
6-phosphate) in frozen and thawed nuclear fractions 
was -lo-15% of that of the homogenate (table 1). 
The total activities, however, were only 0.3-0.4% of 
the total cellular activities of the enzyme. Both the 
specific activities and the ratio of nuclear to total 
glycogen synthase did not change significantly in 
diabetic rats and diabetic rats treated with glucose 
and insulin (5 U/Kg body wt) (14 days following 
treatment with streptozotocin). 
Nuclear glycogen synthase was assayed immediately 
following the isolation procedure (~4 h after sacrifice) 
and the homogenate glycogen synthase was assayed 
immediately following homogenization (20 mm after 
sacrifice) and again together with the nuclear frac- 
tion. The independent activities of glycogen synthase 
increased 2-3-fold in the homogenate during the 3.5 h 
required for subsequent isolation of the nuclear 
fraction. Nevertheless, nuclei suspended in the same 
medium for the same time and the same temperature 
(04°C) consistently displayed a lower independent 
activity of glycogen synthase than the enzyme in 
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Table 1 
Fraction and time of assay 
Homogenate 
+20 min %4h 
Nuclei 
%4h 
Normal rats 
Spec. act. 
(nmol . mg-’ . mm’) 
%I 
% of total 
Diabetic 
Spec. act. 
(nmol . mg-’ min-‘) 
%I 
% of total 
Diabetic 
insulin-treated 
Spec. act. 
(nmol . mg-’ . min-‘) 
%I 
% of total 
2.97 r 1.61 (18) 
18.1 ?: 4.9 (14) 
_ 
3.9 (2) 
11 (2) 
_ 
3.3 (2) 
15 (2) 
_ 
4.01 f 2.56 (14) 
50.4 f 10.5 (14) 
_ 
4.6 (2) 
32 (2) 
_ 
4.1 (2) 
37 (2) 
_ 
0.59 f 0.58 (9) 
11.9 k5.5 
0.36 ? 0.14 
0.45 (2) 
7.5 (2) 
0.27 (2) 
0.51 (2) 
14 (2) 
0.41 (2) 
Purified nuclear fraction and liver homogenates were assayed at the indicated times (fol- 
lowing sacrifice) as in section~2. Insulin-treated rats were injected with 3 g/kg glucose i.p. 
and 5 u/kg insulin i.v. and sacrificed 2.5 h later. The results are the near of a number of 
independent experiments (in parentheses * SEM 
homogenates assayed immediately after homogeniza- 
tion (table 1). This indicates that the nzyme associ- 
ated with nuclei is protected from the glycogen 
synthase phosphoprotein phosphatase. 
Electron microscopic examination of the nuclear 
fraction revealed a preparation which contained 
mostly intact nuclei and very little contaminating 
material. Glycogen particles were detected in many 
nuclei. However, the glycogen particles were consis- 
tently associated with nuclei which displayed damage 
to the nuclear envelope (fig.la-d). Moreover, the 
same nuclei which contained glycogen particles also 
contained other cellular debris (e.g., smooth mem- 
branes and rough endoplasmic reticulum). No gly- 
cogen was detected in nuclei in fixed liver sections 
[ 161. It is apparent that damage to the nuclear enve- 
lope results in a non-specific trapping of cellular 
contents in the partially ruptured nuclei. 
4. Discussion 
The accumulation of glycogen in cell nucleus has 
been ascribed to the transfer of cytoplasmic glycogen 
September 1980 
to the nucleus. The demonstration of glycogen syn- 
thesis in Erlich ascites nuclei [9,10] and massive 
deposits of glycogen in liver nuclei in biopsies obtained 
from diabetics suggested the possibility that nuclear 
synthesis of glycogen might be a feature in some cells. 
In other cells the enzymes involved in synthesis might 
be latent and triggered only by a pathological condi- 
tion (e.g., hepatitis or diabetes). 
Our observations point to the following conclu- 
sions: 
1. The activities of glycogen synthase associated with 
a purified nuclear preparation are below the level 
of contamination of the preparation by cytoplas- 
mic content* (0.5-l%, according to [12]. 
2. Although glycogen particles can be detected inside 
isolated liver nuclei, they are consistently present 
in damaged nuclei and accompanied by the pres- 
ence of other cytoplasmic structures. 
3. Glycogen synthase associated with the nuclear 
* An incomplete perfusion of the tissue to free it from most 
of the blood might be a possible source of error. The 
nuclear pellets from unperfused and partly-perfused livers 
were extensively contaminated with glycogen and, conse- 
quently, very high activity of glycogen synthase 
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Fig.1. (a-d). Micrograph of purified liver nuclei prepared as in section 2. Black arrows indicate nuclei with visible damage of 
nuclear envelope: Glycogen particles (C); rough endoplasmic reticulum (RER); smooth membranes (SM). 
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fraction appears to be protected from the action 
of cellular glycogen synthase phosphatase. 
We conclude that the low activity detected in the 
nuclear fraction is most probably due to glycogen 
synthase adsorbed on glycogen particles trapped with 
other cytoplasmic structures in damaged nuclei. The 
trapping will explain the resistance of the enzyme to 
the action of cytoplasmic phosphatase. The presence 
of glycogen particles in nuclei and/or the high activity 
of glycogen synthase associated with purified nuclear 
fraction might indicate a preparation containing a 
high proportion of damaged nuclei and might be a 
useful criterion for the degree of the damage. 
There was no significant change in the activity of 
glycogen synthase in nuclear preparations from 
untreated and insulin-treated streptozotocindiabetic 
rats. This, however, does not exclude the possibility 
of glycogen accumulation in the nuclei of tissues of 
diabetics suffering from this disorder for an extended 
period of time. 
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